{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:21:26Z","timestamp":1791951686821,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejphar.2019.03.039","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T12:36:46Z","timestamp":1553776606000},"page":"247-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors"],"prefix":"10.1016","volume":"853","author":[{"given":"Salla","family":"Mansikkam\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saku T.","family":"Sinkkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa R.","family":"Korpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"L\u00fcddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.03.039_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/acer.12957","article-title":"Inhibitors of calcium-activated anion channels modulate hypnotic ethanol responses in adult sprague dawley rats","volume":"40","author":"Carter","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2019.03.039_bib2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature04223","article-title":"BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain","volume":"438","author":"Coull","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.03.039_bib3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nature01868","article-title":"Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain","volume":"424","author":"Coull","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.03.039_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuint.2007.04.017","article-title":"Characterization of the interaction between fenamates and hippocampal neuron GABA(A) receptors","volume":"51","author":"Coyne","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2019.03.039_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs","volume":"104","author":"Cryer","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2019.03.039_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1124\/jpet.109.161885","article-title":"Limiting activity at beta 1-subunit-containing GABAA receptor subtypes reduces ataxia","volume":"332","author":"Gee","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.03.039_bib7","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2147\/JPR.S146399","article-title":"Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies","volume":"10","author":"Grilli","year":"2017","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2019.03.039_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pharmthera.2013.01.012","article-title":"Flufenamic acid as an ion channel modulator","volume":"138","author":"Guinamard","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.03.039_bib9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.2042-7158.2012.01479.x","article-title":"Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels","volume":"64","author":"Gwanyanya","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(79)90343-X","article-title":"Tolfenamic acid is as effective as ergotamine during migraine attacks","volume":"2","author":"Hakkarainen","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.03.039_bib11","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1046\/j.1460-9568.1999.00709.x","article-title":"Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid","volume":"11","author":"Halliwell","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2019.03.039_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuint.2009.04.008","article-title":"Brain regional distribution of GABA(A) receptors exhibiting atypical GABA agonism: roles of receptor subunits","volume":"55","author":"Halonen","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2019.03.039_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(88)90556-2","article-title":"Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats","volume":"462","author":"Ikonomidou-Turski","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2019.03.039_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/mol.105.015206","article-title":"Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models","volume":"69","author":"Joo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1096\/fj.02-0611fje","article-title":"General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta 3 subunit","volume":"17","author":"Jurd","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.03.039_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tins.2013.08.006","article-title":"Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2","volume":"36","author":"Kahle","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2019.03.039_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuint.2009.06.014","article-title":"Evidence for neuroprotection by the fenamate NSAID, mefenamic acid","volume":"55","author":"Khansari","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2019.03.039_bib18","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.118.211144","article-title":"Evaluation of two potent and selective PET radioligands to image COX-1 and COX-2 in rhesus monkeys","author":"Kim","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2019.03.039_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.03.039_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1124\/pr.115.010967","article-title":"Mechanisms of action and persistent neuroplasticity by drugs of abuse","volume":"67","author":"Korpi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2019.03.039_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-0082(02)00013-8","article-title":"Drug interactions at GABA(A) receptors","volume":"67","author":"Korpi","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0026-895X(25)08539-6","article-title":"Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor","volume":"47","author":"Korpi","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjp.0700922","article-title":"Furosemide interactions with brain GABAA receptors","volume":"120","author":"Korpi","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0014-2999(92)90402-P","article-title":"GABAA antagonists reveal binding sites for [35S]TBPS in cerebellar granular cell layer","volume":"211","author":"Korpi","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib25","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1471-4159.1996.66052179.x","article-title":"Modulation of GABAA receptor tert-[35S]butylbicyclophosphorothionate binding by antagonists: relationship to patterns of subunit expression","volume":"66","author":"Korpi","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2019.03.039_bib26","article-title":"In vivo brain imaging, biodistribution, and radiation dosimetry estimation of [(11)C]celecoxib, a COX-2 PET ligand","volume":"vol. 23","author":"Kumar","year":"2018"},{"key":"10.1016\/j.ejphar.2019.03.039_bib27","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/346648a0","article-title":"Cerebellar GABAA receptor selective for a behavioural alcohol antagonist","volume":"346","author":"Luddens","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.03.039_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/mol.52.3.380","article-title":"Cerebellar gamma-aminobutyric acid type A receptors: pharmacological subtypes revealed by mutant mouse lines","volume":"52","author":"Makela","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.108.144568","volume":"327","author":"Munro","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.03.039_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.03.039_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejphar.2019.03.039_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0376-8716(83)90016-9","article-title":"Prostaglandins in alcohol intolerance and hangover","volume":"11","author":"Parantainen","year":"1983","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2019.03.039_bib33","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1038\/ncomms7803","article-title":"Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype","volume":"6","author":"Ralvenius","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2019.03.039_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(87)90198-4","article-title":"The chloride channel blocking agent, t-butyl bicyclophosphorothionate, binds to the gamma-aminobutyric acid-benzodiazepine, but not to the glycine receptor in rodents","volume":"76","author":"Rienitz","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2019.03.039_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0896-6273(89)90257-2","article-title":"Two novel GABAA receptor subunits exist in distinct neuronal subpopulations","volume":"3","author":"Shivers","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2019.03.039_bib36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2019.03.039_bib37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/mol.64.3.753","article-title":"Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug","volume":"64","author":"Sinkkonen","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0169-328X(00)00275-8","article-title":"Characterization of gamma-aminobutyrate type A receptors with atypical coupling between agonist and convulsant binding sites in discrete brain regions","volume":"86","author":"Sinkkonen","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.ejphar.2019.03.039_bib39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/jpet.104.070342","article-title":"Compounds exhibiting selective efficacy for different beta subunits of human recombinant gamma-aminobutyric acid A receptors","volume":"311","author":"Smith","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.03.039_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","article-title":"Virtual computational chemistry laboratory--design and description","volume":"19","author":"Tetko","year":"2005","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejphar.2019.03.039_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2019.03.039_bib42","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1136\/thorax.55.suppl_2.S3","article-title":"Aspirin and other anti-inflammatory drugs","volume":"55","author":"Vane","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2019.03.039_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pnpbp.2017.05.012","article-title":"Epidemiology of pain and relation to psychiatric disorders","volume":"87","author":"Velly","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.03.039_bib44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0022-3565(25)39014-2","article-title":"Effects of fenamates and other nonsteroidal anti-inflammatory drugs on rat brain GABAA receptors expressed in Xenopus oocytes","volume":"268","author":"Woodward","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.03.039_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1476-5381.1992.tb14203.x","article-title":"Non-competitive inhibition of GABAA responses by a new class of quinolones and non-steroidal anti-inflammatories in dissociated frog sensory neurones","volume":"105","author":"Yakushiji","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00424-011-0988-4","article-title":"GABAA receptors involved in sleep and anaesthesia: beta 1- versus beta 3-containing assemblies","volume":"463","author":"Yanovsky","year":"2012","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.ejphar.2019.03.039_bib47","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/j.1460-2075.1989.tb03557.x","article-title":"GABAA receptor \u00df subunit heterogeneity: functional expression of cloned cDNAs","volume":"8","author":"Ymer","year":"1989","journal-title":"EMBO J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:07:48Z","timestamp":1762142868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919302006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":47,"alternative-id":["S0014299919302006"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.039","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}